Conférences - Pharmacologie et développement des médicaments

Discover the critical factors for successful implementation and sustainability of Key Account Management (KAM) programmes in Pharma - Master an 8-step model for making the right strategic decisions, whilst promoting greater multi-functional working - Learn key insights and case-study examples to avoid typical pitfalls that have caused failures in the past.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [0086-411-84799609-826];     Email.: jessica@iddst-china.com

Breaking Drug Discovery Research, Smart Screening for Hits to Leads, Emerging Drug Targets, Immunotherapy, Informatics Frontier, Preclinical Evaluation, Bioprocessing of Biotherapy, Natural Products & TCM, Smart Drug Design, Major Disease INDs

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Grasp the meaning, concepts, terminology, methodologies and research techniques of Real World Evidence (RWE) in the context of optimising Market Access - Know what each stakeholder type expects from RWE, which key data to use and how to develop a successful RWE study – Learn how to incorporate RWE into the product pre-launch process.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Peptide Drug Discovery: a Niche Area?

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Grasp the organizational implications of the different HTA outcomes in key European markets – Learn the different approaches and decision criteria used by major HTA bodies, as well as the critical success factors when preparing for HTA submissions – Know the reasons why outcomes and recommendations might vary, as well as the nuances of evaluating orphan drugs.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Pharma conference 2019 will have an intensive 2-day program with a wide range of topics covering pharmacy practice, pharmaceutical science, pharmacology, pharmacovigilance, and many other pharmaceutical developments. World-renowned speakers and eminent delegates across the globe attending the conference, to share their valuable presentation on the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.

Tél.: [442088910774];     Email.: Pharma@pharmameet.org

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Spreadsheet Applications such as MS Excel are frequently used in 21 CFR 11 compliant environments, but they were not specifically designed for regulated environments and their development is not optimized for 21 CFR 11 compliance. However, the FDA expects that spreadsheets be compliant and lack of compliance can result in a warning letter. Consequently, validation of Excel Spreadsheet Applications is required as part of a 21 CFR 11 compliant environment.

Traininng.com LLC;     Tél.: [(510) 962-8903];     Email.: traininngdotcom@gmail.com

Learning destination for professionals courses, world class professionals trainings, professionals training courses

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

The day is aimed at medical and non-medical delegates who are new to assessing, authorising and prescribing SACT.

Conference Team;     Tél.: [02078082921];     Email.: conferenceteam@rmh.nhs.uk

Pharmaceutical Microbiology as an industry is projected to see significant advancements in the next five years. This forecast is largely attributed to rapid microbiology testing, which has accounted for $3.5 billion last year, while projected to reach nearly double at $6 billion by 2025, and an estimated CAGR of 8.3% leading up to 2025. At the very core of pharmaceutical microbiology is the accurate and reliable detection of microorganisms that would otherwise contaminate the pharmaceutical products manufactured. This demand for more rapid methods for detection and identification will be accompanied by equally important areas such as: contamination control strategies and environmental monitoring, process automation, and discussing updates to meet regulatory requirements.

Join us at SMi’s 9th Annual Pharmaceutical Microbiology Conference to explore novel and developing technologies that tackle the most pressing challenges and push innovation in world of pharmaceutical microbiology.

Tél.: [07800890224];     Email.: ssapal@smi-online.co.uk

Pharmaceutical Microbiology, Microbiology, Pharmaceuticals, Aseptic Technique, Sterility, Bioburden, Mycoplasma, Quality Control, Rapid Microbial Methods, Data Integrity, Risk Assessments, Environmental Monitoring

Génie biomédical,    Microtechnologie, nanotechnologie

Cambridge Healthech Institute

PepTalk delivers a wide scientific spectrum featuring case studies, unpublished data, breakthroughs & solutions that support and enhance biotherapeutic research, plus an exhibit hall featuring technology & service providers, and 150+ research posters

Cambridge Healthtech Institute;     Tél.: [7819725400];     Email.: chi@healthtech.com

antibodies, antibody therapeutics, antibody-drug conjugates, biologics, biotech, biotechnology, biotherapeutics, cell, gene therapy, life sciences, medical science, protein, protein aggregation, protein expression, science, the protein science week, bioengineering, bio engineering, bio-engineering, bioscience

Chemical biology is a scientific discipline that promises to apply the latest chemical approaches to interrogate complex biological systems and is, consequently, at the very heart of modern pharmacology. This conference will explore how recent advances in chemical biology are helping to expand the druggable proteome and enhance our understanding of disease biology .

EMBL Events;     Tél.: [+49 6221 387 8797];     Email.: events@embl.de

Drug discovery, chemical biology, genomics, DNA-sensing pathways, proteolysis targeting chimeras (PROTACs), targeted protein degradation, druggable proteome, druggable genome, phenotypic screens, chemical probes, chemogenomics, bioinformatics

SMi Group

SMi’s 3D Cell Culture Conference will explore advances of organ and lab-on-a-chip, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field. For the first time ever the NEW 3D Bioprinting Focus Day on 18 February 2020 will explore case studies from big pharma, biotech’s and academia exploring how bioprinting is being used in industry highlighting projects looking at stem cell therapy, drug screening and extracellular matrix scaffolds.

Tél.: [02078276000];     Email.: ssapal@smi-online.co.uk

Organ-on-chips, microfluidics, cell culture, 3D cell culture, 3D bioprinting, bioprinting, organoid, extracellular matrix, ECM, tissue engineering, physiochemical factors, cell-based assay, cytotoxicity, cell metabolic pathways, cancer research, molecular diagnostics, cell and gene therapy, microphysiological, co-culture systems complex in-vitro models, high throughput screening, 3D imaging, drug screening, extracellular matrix scaffolds, 3D drug development, regenerative therapies

Cellules souches,    Législation en médecine et pharmacologie

King Abdullah International Medical Research Center (KAIMRC)

2nd Therapeutics Discovery From Bench to Fist in Human Trials conference provides a unique opportunity for experts around the world to come together, learn and discuss the latest research update on drug discovery and development. It is a unique in its kind to be hosted in the newly opened research facility at King Abdullah International Medical Research Center (KAIMRC) that is aimed to boost the academic drug discovery and development research (DDDR) in the Kingdom of Saudi Arabia and link it with the international recognized body in the field.

Email.: KAIMRC-Therapeutics@ngha.med.sa

Themes that will be discussed in two days and each will include Keynote presentations, selected abstract presentation and panel discussions. Academic Drug Discovery Platforms, Rare Diseases Targets and Orphan Drugs Discovery, Artificial Intelligence in Drug Discovery, Anti-Infective Drug Discovery in the Era of Bad Bugs, Natural Products as source of novel drug.

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

The ECI “Delivery of Nucleic Acid Therapeutics: Biology, Engineering and Development” conference will provide a forum for increasing our mechanistic understanding of the biological processes underpinning non-viral and viral delivery, including molecular and cellular biology, virology, in vivo pharmacology and toxicology, rational optimization strategies, targeting, formulation, bioengineering and process development solutions to scale-up and manufacturing, regulatory considerations and preclinical and clinical NAT programs.

Tél.: [212516760];     Email.: noel@engconfintl.org

nucleic acid RNA mRNA viral drug development vectors tropism virology NAT cargo ASO's Therapeutics

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Join us at our 3rd Annual Formulation & Drug Delivery USA Congress - Over 300 delegates - Over 55 case studies & Presentations - Six highly interactive streams

Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk

Formulation, Drug Delivery, Drug Development, Cell & Gene Therapy

Oxford Global

Tél.: [+441865248455];     Email.: e.hawkings@oxfordglobal.co.uk

Respiratory, Drug Delivery, Inhalation, Pharmaceutical

In the light of this theme “Future breakthrough in Toxicology and Pharmacology for the better world”, Toxicology and Pharmacology Summit aims to provide a forum for international researchers and academicians from various areas of biology, chemistry, pharmacology, and medicine by providing one kind of platform for critical analysis of new designing, and to share latest cutting-edge research findings, most recent movements and latest upgrades inside the field of Pharmacology with explicit keynote lectures, plenary sessions, Poster competition, Young Researchers’ Forum (YRF), Workshops, Symposiums and Exhibitions from elite researchers, distinguished scientists and business delegates. It allows delegates to have issues addressed on Toxicology & Pharmacology by recognized global experts who are up to date with the latest developments in the field to a common forum and also exchange ideas makes us updated about the advancements and innovations in Toxicology and Pharmacology in a wide range.

Tél.: [1 631 303 3007];     Email.: toxicology.us@gmail.com

Medicine Development and Safety Testing, Therapeutic Drug Monitoring and Drug, Environmental and Occupational Toxicology, Developmental Pharmacology, Molecular and Biochemical Toxicology, Reproductive and Developmental Toxicology, Applied Pharmacology, Genetic Toxicology and Toxicity Testing, Product Development Toxicology, Industrial & Occupational Toxicology, Toxicological Pharmacovigilance, Toxicologic Pathology, Clinical Trials on different Diseases and Medical Devices, Toxicology Consulting, Genetic and Cellular Toxicology, Aquatic Toxicology, Toxicology Global Market, Toxicology Current Advances, Pharmacology and Drug Design, Pharmacological Testing, Toxicology Risk Assessment, Immunopharmacology and Immunotoxicology, Advances in Pharmacological Research, Market Analysis of Pharmacology, Biochemical pharmacology, Cardiovascular Pharmacology.

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

The rising tide of counterfeit medicines are turning into a serious concern around the world, and have progressively been showing up through the real pharmaceutical supply chain, including community and online drug stores.Counterfeit drugs are not only a global public health risk, but also harm the quality of the product, the integrity of the brand, the economy and even national security.We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters.

Tél.: [02070960786];     Email.: info@corvusglobalevents.com

PharmaSecurityWorld, counterfeitdrugs, Anticounterfeiting, BrandProtection, drugsecuritySerialization, Traceability, SupplyChain, IP, PharmaSupplyChain, Packaging, BrandEnforcement, BrandIntegrity, Labelling, Printing, TrackAndTrace, DrugRegulatory, RFID, fakedrugs

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn to design a digital innovation strategy for Medical Affairs – Grasp the full power and trends of the whole spectrum of digital tactics that affect physicians and patients – Learn how to optimise the mix of tactics and to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Corvus Global Events

The Annual Pharma Supply Chain and Security World Summit is back in London for the 3rd time, and this time with more focus on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. Pharmaceutical companies have to resist the challenges looming from supply chain security lapses to avoid infiltration of counterfeit, diverted, and adulterated drugs entering into the supply chain. To protect your brand and build a genuine future, Corvus Global Events invites you to Pharma Supply Chain & Security World 2020 - Supply-chain, Drug Serialization And Anti-Counterfeiting conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas, the conference will also offer opportunities to encourage partnerships and collaborations. In this conference you’ll not only discover innovative technologies, transformation strategies and collaboration methods, but how best to implement them to optimise your supply chain processes and strategies for drug anti-counterfeiting.

Corvus Global Events;     Tél.: [+442070960786];     Email.: info@corvusglobalevents.com

PharmaSecurityWorld, SupplyChain, counterfeitdrugs, Anticounterfeiting, BrandProtection, drugsecurity Serialization, Traceability, SupplyChain, IP, PharmaSupplyChain, Packaging, BrandEnforcement, BrandIntegrity, Labelling, Printing, TrackAndTrace, DrugRegulatory, RFID, fakedrugs

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Cambridge Healthtech Institute

Cambridge Healthtech Institute's 15th Annual Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, Drug Discovery Chemistry provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's personal interests by going back and forth among concurrent conferences. The 2020 event includes new coverage of RNA as a small molecule target, expanded coverage of artificial intelligence for early drug discovery, plus even more short courses to choose from.

Marketing Manager;     Email.: asaenger@healthtech.com

drug discovery, small molecules, therapeutics, medicinal chemistry

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Oxford Global

Over 150 attendees working in peptides and oligonucleotides, representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions. Over 40 case studies, presentations and panel discussions focused on the key issues in peptide technologies, therapeutics case studies, discovery & development of oligonucleotide therapeutics, manufacturing and process development.

Tél.: [+441865248455];     Email.: b.copeman@oxfordglobal.co.uk

Peptide, Oligonucleotide, Peptide Chemistry, Peptide Characterisation, Peptide Purification, Peptide Discovery, Peptide Research, Antimicrobial Peptides, Peptide Synthesis, Peptide Manufacturing, Peptide Bioavailability, Peptide Toxicity, Peptide Process Development, Peptide Therapeutics, Peptide, Immunogenicity, Peptide Immunology, Peptide Stability, Peptide Automation, Peptide Half Life Extension, Peptide Novel Diseases, Peptide Endocrinology, Peptide Infectious Diseases, Peptide Oncology

Epigenetics is a field that impinges on many biological processes since it encompasses fundamental mechanisms of gene regulation. In addition, this area is currently exploited for drug development, particularly against cancer, since epigenetics regulators are miss-regulated in this disease. The conference will bring together all these themes. It will provide a comprehensive backdrop to the basic principles behind Epigenetic and cross-reference to their relevance to disease. There will be sessions on Chromatin, RNA and DNA regulatory pathways and a separate session on recent developments in drug discovery from Pharma.

Conference Manager;     Tél.: [00441638724137];     Email.: admin@fusion-conferences.com

Epigenetics, Cancer, Chromatin regulatory pathways, RNA modification pathways, DNA modification pathways, Drug discovery

Génomique et bio-informatique,    Cancérologie

Engineering Conferences International (ECI)

It is well known that the physical and chemical properties of the DS (API) have major impacts on the formulation and the Drug Product (DP) process. In any dosage form including solid, liquid and semi-solid, the Drug Substance (DS) or Active Pharmaceutical Ingredient (API) goes through a formulation process. This process to make the final drug product serves many purposes, but all with the goal of eventually delivering the active ingredient to the desired sites in the patients’ body in the most convenient way and to achieve optimal therapeutic effect.

Tél.: [2125146760];     Email.: noel@engconfintl.org

Role particle engineering process scaleup Pharmaceutical composite materials DS/DP interface integration DS (API)

Learn how to engage patients with multi-channel disease awareness / patient activation campaigns – Know how to support patients in their therapy with multi-stakeholder / multi-channel patient adherence programmes – Be able to measure success and impact on the critical success factors of a patient-centric organisation.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the drivers of patient health behaviours – Learn how to identify and interpret specific individual drivers of health behaviours – Understand the practical steps to design/enhance your support solutions in a way that delivers true personalisation and support for all stakeholders - Take your current patient/caregiver/HCP support solution(s) to the next level with insights from Professor John Weinman and Nathan O’Donnell.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the role of MSLs within the organisation – Gain business acumen by understanding how the MSL can optimally add value to both external and internal stakeholders – Know how strategic decisions determine MSL tactics – Learn how to successfully plan and implement typical MSL tactics, and how to assess their impact – Discuss and discover how to deal with issues that MSLs typically are confronted with.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Prepare for patent expiry with a winning LCM plan for established brands – Know which drivers of differentiation can be used – Learn where, when and how to compete in a generic world using late stage LCM strategies & tactics – Learn how to make portfolio management decisions for mature brands.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to analyse your brand’s market so that you discover all sales levers – Know how to determine priority segments and define a value positioning statement – Learn how to design the optimal mix of marketing tactics in both Red (highly competitive) & Blue (highly innovative) Ocean markets.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Master the critical success factors of a commercial drug launch: Selecting the right launch type – A structured roadmap – The critical market insights you need to gain in pre-launch phases – Identifying leverage points along the patient journey – Defining and prioritising customer segments - Designing the most effective omni-channel strategy and plan.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the language, the concepts and research techniques in pharmaceutical pricing – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

This conference focuses on the design, synthesis and clinical validation of new drug delivery vehicles. This conference is designed to bridge the gap between basic science and unmet clinical needs.

Conference Manager;     Tél.: [00441638724137];     Email.: admin@fusion-conferences.com

Therapeutic gene editing, Extrahepatic delivery of nucleic acids, Characterization of therapeutic nanoparticles and control strategies for manufacturing, New linkers for triggered or controlled release, New long acting technologies, Tumor targeting with nanoparticles, recent progress and challenges

Pharmacogénétique, Médecine personnalisée,    Législation en médecine et pharmacologie

Tél.: [+31887569555];     Email.: congress2020@ecnp.eu

brain disorder, health, neurology, pharma, mental disorder

Neurologie,    Psychiatrie

Learn to design a digital innovation strategy for Medical Affairs – Grasp the full power and trends of the whole spectrum of digital tactics that affect physicians and patients – Learn how to optimise the mix of tactics and to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the role of MSLs within the organisation – Gain business acumen by understanding how the MSL can optimally add value to both external and internal stakeholders – Know how strategic decisions determine MSL tactics – Learn how to successfully plan and implement typical MSL tactics, and how to assess their impact – Discuss and discover how to deal with issues that MSLs typically are confronted with.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to engage patients with multi-channel disease awareness / patient activation campaigns – Know how to support patients in their therapy with multi-stakeholder / multi-channel patient adherence programmes – Be able to measure success and impact on the critical success factors of a patient-centric organisation.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Biogate Scientific Center welcomes Vaccines Summit Ohio (VSOhio20) in Columbus, OH from October 05-07, 2020. VSOhio20 will cover a broad range of topics like animal models, clinical trials, big data, and analytics. The summit will bring together participants from around the globe, including high-level political decision-makers, health ministers, UN organizations, NGOs, academia representatives, renowned researchers and healthcare professionals, vaccine industry CEOs, celebrities and social media influencers who actively support vaccination.

Tél.: [+1 410 246 4289];     Email.: sachin@bsc.events

Vaccine Technology, Animal Models, Influenza Vaccines, Vaccine Safety Science, Regulatory Science, Clinical Evaluation, Nonclinical Development, Vaccine Hesitancy, Big data and Analytics

Master the critical success factors of a commercial drug launch: Selecting the right launch type – A structured roadmap – The critical market insights you need to gain in pre-launch phases – Identifying leverage points along the patient journey – Defining and prioritising customer segments - Designing the most effective omni-channel strategy and plan.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the language, the concepts and research techniques in pharmaceutical pricing – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Prepare for patent expiry with a winning LCM plan for established brands – Know which drivers of differentiation can be used – Learn where, when and how to compete in a generic world using late stage LCM strategies & tactics – Learn how to make portfolio management decisions for mature brands.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to engage patients with multi-channel disease awareness / patient activation campaigns – Know how to support patients in their therapy with multi-stakeholder / multi-channel patient adherence programmes – Be able to measure success and impact on the critical success factors of a patient-centric organisation.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to analyse your brand’s market so that you discover all sales levers – Know how to determine priority segments and define a value positioning statement – Learn how to design the optimal mix of marketing tactics in both Red (highly competitive) & Blue (highly innovative) Ocean markets.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the marketing principles that determine a pharmaceutical’s commercial success - Learn how your function can contribute to a pharma brand’s success in the new environment - Know how pharma marketers take strategic and tactical decisions - Gain ideas for cross-functional synergies that benefit a brand’s success.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the drivers of patient health behaviours – Learn how to identify and interpret specific individual drivers of health behaviours – Understand the practical steps to design/enhance your support solutions in a way that delivers true personalisation and support for all stakeholders - Take your current patient/caregiver/HCP support solution(s) to the next level with insights from Professor John Weinman and Nathan O’Donnell.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the role of MSLs within the organisation – Gain business acumen by understanding how the MSL can optimally add value to both external and internal stakeholders – Know how strategic decisions determine MSL tactics – Learn how to successfully plan and implement typical MSL tactics, and how to assess their impact – Discuss and discover how to deal with issues that MSLs typically are confronted with.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the language, the concepts and research techniques in pharmaceutical pricing – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn to design a digital innovation strategy for Medical Affairs – Grasp the full power and trends of the whole spectrum of digital tactics that affect physicians and patients – Learn how to optimise the mix of tactics and to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Master the critical success factors of a commercial drug launch: Selecting the right launch type – A structured roadmap – The critical market insights you need to gain in pre-launch phases – Identifying leverage points along the patient journey – Defining and prioritising customer segments - Designing the most effective omni-channel strategy and plan.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com